Trials / Completed
CompletedNCT00238862
Treatment of PED With AMT and Autologous Serum
Efficacy of Amniotic Membrane Transplantation and Autologous Serum in Treatment of Persistent Epithelial Defects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (planned)
- Sponsor
- King Khaled Eye Specialist Hospital · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients with persistent corneal epithelial defects who have not responded to conventional therapy will be randomized to treatment with either amniotic membrane transplantation or autologous serum 20%. Outcome measures will be (1) presence or absence of complete re-epithelialization within 28 days and (2) retention of intact epithelium for at least 90 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Amniotic membrane transplantation | |
| DRUG | Autologous serum/BSS 20% |
Timeline
- Start date
- 2005-10-01
- Completion
- 2006-09-01
- First posted
- 2005-10-14
- Last updated
- 2021-12-02
Locations
1 site across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT00238862. Inclusion in this directory is not an endorsement.